Otrivin (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Otrivin, is an alpha‑2‑adrenergic agonist presented as a nasal spray for topical intranasal use. It relieves nasal congestion associated with colds, sinusitis and allergic rhinitis in adults and children. GNH USA supplies Otrivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otrivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivin acts on the nasal mucosa to reduce swelling and improve airflow.

- Common cold: alleviates nasal congestion and improves breathing. - Sinusitis: reduces mucosal edema, facilitating sinus drainage. - Allergic rhinitis: decreases nasal blockage caused by allergic inflammation. - Nasal surgery recovery: helps maintain clear nasal passages post‑operatively.

Adverse reactions are generally mild and related to local irritation of the nasal mucosa.

Common Side Effects: - Burning sensation: mild burning or stinging feeling in the nose. - Nasal dryness: sensation of dryness or crusting inside the nostrils. - Sneezing: transient sneezing episodes after application. - Headache: mild headache associated with nasal decongestion.

Serious or Rare Side Effects: - Rebound congestion: worsening nasal blockage after prolonged use. - Nasal ulceration: rare ulcer formation on the nasal mucosa. - Severe allergic reaction: hives, swelling, or difficulty breathing. - Hypertensive crisis: rare elevation of blood pressure in susceptible individuals.

Before using Otrivin, consider the following safety measures:

- Contraindication: Do not use if   - Pregnancy   -         ewline -     ewline -  ewline   -  -  -  ewline   ---   ---  - ",